Pharmacovigilance has had its focus on the many adverse drug reactions known as ADR’s that refers to a sudden, un-predicted response of a drug that can be peril to public health. In due course of time, India lacked the necessary resources to help tackle situations across the country in response to any drug reaction/ side effects. Adverse drug reactions may occur in many ways like that of, over-doses, in-correct usage & drug-abuse are the reasons why pharmacovigilance programmes are in need for the future of the nation. Pharmacovigilance concerns with the hazards of a drug that is marketed & to help reduce its risk-factors.
The appropriate data is collected at the adverse drug reaction centres that are useful for analysis & further aid to formulate safety measures of a drug in India, said one of its advisors for Pharmacovigilance Programme of India- Dr. S.K.Gupta. Pharmacovigilance does not stop here in India, However, the World Health Organization (WHO) & Uppsala Monitoring Centre (UMC) have served to be a part of the ADR centres as well. In India, the Drug Safety Associates/ Executives/ Managers have the right to access data on adverse drug reaction reports from across the world. The IPC claims to set up about 350 adverse drug reaction centres in India, by making the pharmacovigilance programme the largest in India. Hence, to improve & sharpen skills for medical students to adhere to pharmacovigilance programmes / courses to meet the demands of the drug’s post-marketing sector, Students & professionals can opt for Pharmacovigilance programmes at James Lind Institute, which aims to give this country an extra-edge over pharmacovigilance aspects.
